From biodefence to biosecurity: The Obama administration's strategy for countering biological threats

International Affairs

Volumn 88, Issue 1, 2012, Pages 131-148

  Koblentz, Gregory D ^a  

^a GEORGE MASON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOLOGICAL WARFARE; BIOLOGICAL WARFARE AGENT; CIVIL DEFENSE; ECONOMICS; EDUCATION; EPIDEMIC; ETHNOLOGY; GOVERNMENT; HISTORY; INTERNATIONAL COOPERATION; LEGAL ASPECT; ORGANIZATION AND MANAGEMENT; PANDEMIC; PSYCHOLOGICAL ASPECT; PUBLIC HEALTH; UNITED STATES;

BIOLOGICAL WARFARE; BIOLOGICAL WARFARE AGENTS; BIOTERRORISM; CIVIL DEFENSE; DISEASE OUTBREAKS; GOVERNMENT; HISTORY, 21ST CENTURY; INTERNATIONAL COOPERATION; PANDEMICS; PUBLIC HEALTH; SECURITY MEASURES; UNITED STATES;

EID: 84856153847     PISSN: 00205850     EISSN: 14682346     Source Type: Journal    
DOI: 10.1111/j.1468-2346.2012.01061.x     Document Type: Article

References (84)

1. Barack Obama, National Strategy for Countering Biological Threats (Washington DC: National Security Council, Nov. 2009), p. 1.
2. For more on the concept of biosecurity, see Gregory D. Koblentz, 'Biosecurity reconsidered: calibrating biological threats and responses', International Security 34: 4Spring 201096-132.
3. Commission on the Prevention of Weapons of Mass Destruction Proliferation and Terrorism, World at risk (New York: Vintage, 2008), p. 11.
4. Obama, National Strategy for Countering Biological Threats 8 13, 15-16.
5. National Science Advisory Board for Biosecurity (NSABB), accessed 11 Dec. 2011.
6. Obama, National Strategy for Countering Biological Threats, p. 13.
7. Obama, National Strategy for Countering Biological Threats, pp. 3
8. Obama, National Strategy for Countering Biological Threats, pp. 4
9. WHO, International Health Regulations (2005), 2nd edn (Geneva: WHO, 2008), p. 43.
10. Rebecca Katz, 'Public health preparedness: the best defense against biological weapons', Washington Quarterly 25: 3, Summer 200269-82.
11. Kaiser Family Foundation and Pew Global Attitudes Project, A global look at public perceptions of health problems, priorities, and donors: the Kaiser/Pew Global Health Survey (Menlo Park, CA, and Washington DC: Kaiser Family Foundation and Pew Global Attitudes Project, 2007), p. 2.
12. Koblentz, 'Biosecurity reconsidered', pp. 96-132.
13. Obama, National Strategy for Countering Biological Threats, p. 6.
14. Obama, National Strategy for Countering Biological Threats, pp. 10-13.
15. Bruce Budowle, Steven E. Schutzer, Anja Einseln, Lynda C. Kelley, Anne C. Walsh, Jenifer A. L. Smith, Babetta L. Marrone, James Robertson and Joseph Campos, 'Building microbial forensics as a response to bioterrorism', Science 301: 5641, 26 Sept.20031852-3
16. Jay C. Butler, Mitchell L. Cohen, Cindy R. Friedman, Robert M. Scripp and Craig G. Watz, 'Collaboration between public health and law enforcement: new paradigms and partnerships for bioterrorism planning and response', Emerging Infectious Diseases 8: 10, Oct. 20021152-6.
17. Obama, National Strategy for Countering Biological Threats, p. 6.
18. Institute of Medicine and National Research Council, Globalization, biosecurity, and the future of the life sciences (Washington DC: National Academies Press, 2006), pp. 79-112.
19. WHO, 'Changes in reporting requirements for pandemic (H1N1) 2009 virus infection', Pandemic (H1N1) 2009 Briefing Note 3 (revised), 16 July 2009, accessed 11 Dec. 2011.
20. George W. Bush, Biodefense for the 21st century (Washington DC: White House, 2004), p. 3.
21. Obama, National Strategy for Countering Biological Threats, p. 1.
22. Center for Arms Control and Non-Proliferation, Federal funding for biological weapons prevention and defense, fiscal years 2001 to 2009 (Washington DC: Center for Arms Control and Non-Proliferation, April 2008).
23. Julie Fischer, Eric Lief, Vidal Seegobin and Jen Kates, Mapping the United States government engagement in global public health (Menlo Park, CA: Henry J. Kaiser Family Foundation, 2009), pp. 13-17.
24. George W. Bush, The National Security Strategy of the United States of America (Washington DC: White House, 2006), p. 44.
25. Memorandum from Andrew Weber, Assistant to the Secretary of Defense for Nuclear and Chemical and Biological Defense Programs, 'Subject: including emerging infectious disease into the biodefense mission set', 26 Oct. 2009
26. Elaine M. Grossman, 'Pentagon pulls $1b from WMD-defense efforts to fund vaccine initiative', Global Security Newswire, 27 Aug. 2010.
27. Jenni Rissane, 'Continued turbulence over BWC verification', in Trevor Findlay and Oliver Meier, eds, VERTIC Yearbook 2002 (London: VERTIC, 2002), pp. 75-92.
28. Richard Armitage and Joseph S. Nye, Jr, CSIS Commission on Smart Power: a smarter, more secure America (Washington DC: Center for Strategic and International Studies, 2007).
29. US Department of State, Leading through civilian power: the first Quadrennial Diplomacy and Development Review (Washington DC: Department of State, 2010).
30. Harley Feldbaum and Joshua Michaud, 'Health diplomacy and the enduring relevance of foreign policy interests', PLoS Medicine 7: 4, April 20102.
31. Office of the Press Secretary Washington DC: White House, 5 May 2009, 'Statement by the President on Global Health Initiative 2011.
32. Barack Obama, National Security Strategy (Washington DC: White House, 2010) 49. 39
33. Obama, National Strategy for Countering Biological Threats, p. 6.
34. Secretary of State Hillary Rodham Clinton, 'Foreign policy address at the Council on Foreign Relations', Washington DC, 15 July 2009, accessed 11 Oct. 2010.
35. Anne-Marie Slaughter, A new world order (Princeton, NJ: Princeton University Press, 2004), pp. 169-94.
36. Anne-Marie Slaughter, 'America's edge: power in the networked century', Foreign Affairs 88: 1, Jan.Feb. 2009 94-113.
37. Slaughter, A new world order, pp. 22-23.
38. Caitríona McLeish and Daniel Feakes, 'Biosecurity and stakeholders: the rise of networks and non-state actors', Science and Public Policy 35: 1, Feb. 2008 5-12.
39. Biological Weapons Convention, Report of the Meeting of Experts, Geneva, 18-22 Aug. 2008, BWC/MSP/2008/MX/3 (Geneva: United Nations, 8 Sept. 2008), pp. 3-4.
40. Kristin M. Lord and Marc Lynch, America's extended hand: assessing the Obama administration's global engagement strategy (Washington DC: Center for New American Security, 2010), pp. 19-21.
41. Obama, National Security Strategy, p. 22.
42. Anthony S. Fauci, 'The expanding global health agenda: a welcome development', Nature Medicine 13: 10, Oct. 20071171.
43. John K. Iglehart, 'Advocating for medical diplomacy: a conversation with Tommy G. Thompson', Health Affairs, 4 May 2004, pp. W262-8.
44. William Newbrander, Rebuilding health systems and providing health services in fragile states, occasional paper 7 (Cambridge, MA: Management Sciences for Health, 2007), p. 1.
45. Obama, National Strategy for Countering Biological Threats, pp. 14, 19-20.
46. Crystal Franco and Tara Kirk Sell, 'Federal agency biodefense funding, FY2010-FY2011', Biosecurity and Bioterrorism 8: 2, 2010141, 147
47. Raphael Della Ratta, Preliminary analysis: FY12 budget request for DOD cooperative threat reduction program (Washington DC: Partnership for Global Security, 25 Feb. 2011).
48. Obama, National Strategy for Countering Biological Threats, p. 19.
49. National Research Council, Countering biological threats: challenges for the Department of Defense's nonproliferation program beyond the former Soviet Union (Washington DC: National Academies Press, 2009).
50. Hillary Rodham Clinton, 'Prepared Statement', Confirmation Hearing before the U.S. Senate Committee on Foreign Relations, January 13, 2009, accessed on the website of the Council for Foreign Relations at, 11 October 2010.
51. E. J. Dionne, Jr, 'The Obama doctrine in action', Washington Post, 16 April 2009, accessed 11 Dec. 2011.
52. Obama, National Strategy for Countering Biological Threats, p. 19.
53. US Government Accountability Office (GAO), 'High-containment laboratories: national strategy for 25-6, 29. oversight is needed', GAO-09-574 (Washington DC: GAO, Sept. 2009) 20-1,
54. NSABB, Enhancing personnel reliability among individuals with access to select agents (Washington DC: NSABB, May 2009)
55. National Research Council, Responsible research with biological select agents and toxins (Washington DC: National Academies Press, 2009).
56. David R. Franz, Susan A. Ehrlich, Arturo Casadevall, Michael J. Imperiale and Paul S. Keim, 'The "nuclearization" of biology is a threat to health and security', Biosecurity and Bioterrorism 7: 3, Sept. 2009243-4.
57. David Dishneau, 'Federal panel recommends tighter scrutiny of those who handle deadly pathogens', Associated Press, 11 Jan. 2010.
58. White House, 'Executive order: optimizing the security of biological select agents and toxins in the United States' (Washington DC: Office of the Press Secretary, 2 July 2010).
59. NSABB, Proposed framework for the oversight of dual use life sciences research: strategies for minimizing the potential misuse of research information (Washington DC: NSABB, 2007).
60. Obama, National Strategy for Countering Biological Threats, p.13.
61. Obama, National Strategy for Countering Biological Threats 514.
62. Jonathan B. Tucker, 'Double-edged DNA: preventing the misuse of gene synthesis', Issues in Science and Technology, Spring 2010, p. 23-32.
63. Department of Health and Human Services, 'Screening framework guidance for providers of synthetic double-stranded DNA', Federal Register 75197, 13 Oct. 201062820-32.
64. Kavita Marfatia Berger, William Pinard, Gwenaële Coat and Gerald L. Epstein, Minimizing the risks of synthetic DNA: scientists' views on the U.S. government's guidance on synthetic genomics, summary of January 11 2010 meeting (Washington DC: AAAS Center for Science, Technology and Security Policy, 2010), p. 10.
65. Obama, National Strategy for Countering Biological Threats,8-9, 10, 12, 15-16, 19, 22.
66. William Aldis, 'Health security as a public health concept: a critical analysis', Health Policy and Planning 23: 6, 2008369-75
67. Feldbaum and Michaud, 'Health diplomacy and the enduring relevance of foreign policy interests1-6.
68. E. Davies, 'Securitizing infectious diseases', International Affairs 84: 2, March 2008 295-313.
69. Harley Feldbaum, Building U.S. diplomatic capacity for global health (Washington DC: Center for Strategic and International Studies, 2010), 8.
70. Obama, National Strategy for Countering Biological Threats, 6.
71. Feldbaum, Building U.S. diplomatic capacity for global health, p. 8.
72. Leonard S. Rubenstein and William Newbrander, 'Militarizing Afghan health care', Washington Post, 29 Nov. 2009, accessed 11 Dec. 2011.
73. Yudhijit Bhattarcharjee, 'Panel provides peer review of intelligence research', Science 318: 5856, 7 Dec. 2007, p. 1538.
74. Martin Enserink and David Malakoff, 'The trials of Thomas Butler', Science 302: 5653, 19 Dec. 2003, pp. 2054-63
75. George J. Annas, 'Bioterror and "bioart"-a plague o' both your houses', New England Journal of Medicine 354: 25, 22 June 20062715-20.
76. Commission on the Prevention of Weapons of Mass Destruction Proliferation and Terrorism, World at risk26.
77. Nathaniel Hafer, Cheryl J. Vos, Karen McAllister, Gretchen Lorenzi, Christopher Moore, Kavita M. Berger and Michael Stebbins, 'How scientists view law enforcement: new survey of researchers tells us how to help the communities communicate' K.
78. Obama, National Strategy for Countering Biological Threats, 18.
79. Daniel Grushkin, 'Synthetic bio, meet "FBIo"', The Scientist 24: 5, May 201044.
80. Department of Justice Office of the Inspector General, The Federal Bureau of Investigation's Weapons of Mass Destruction Coordinator Program, audit report 09-36 (Washington DC: Department of Justice, Sept. 2009 47-58.
81. National Intelligence Council, Strategic implications of global health, ICA 2008-10D (Washington DC: National Intelligence Council, Sept. 2008).
82. National Center for Counterproliferation, National Intelligence Strategy for Countering Biological Threats (Washington DC: Office of Director of National Intelligence, Aug.), obtained through the Freedom of Information Act.2007
83. Obama, National Strategy for Countering Biological Threats, pp. 4-5.
84. White House, Implementation of the National Strategy for Countering Biological Threats, Presidential Policy Directive 2 (Washington DC: White House, 23 Nov. 2009).